Patents by Inventor HEATHER KLING

HEATHER KLING has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • KEXIN-DERIVED VACCINES TO PREVENT OR TREAT FUNGAL INFECTIONS
    Publication number: 20230173043
    Abstract: A vaccine is disclosed that promotes CD4+ T cell-independent host defense mechanisms to defend against infection by fungi such as Pneumocystis spp. The vaccine may be used to prevent or to treat fungal infections. The novel vaccine can provide protective immunity, even for immunocompromised individuals such as HIV patients having reduced levels of CD4+ T cells.
    Type: Application
    Filed: July 14, 2022
    Publication date: June 8, 2023
    Applicants: UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College
    Inventors: Jay K. Kolls, Michael Zheng, Karen Norris, Heather Kling
  • KEXIN-DERIVED VACCINES TO PREVENT OR TREAT FUNGAL INFECTIONS
    Publication number: 20210145948
    Abstract: A vaccine is disclosed that promotes CD4+ T cell-independent host defense mechanisms to defend against infection by fungi such as Pneumocystis spp. The vaccine may be used to prevent or to treat fungal infections. The novel vaccine can provide protective immunity, even for immunocompromised individuals such as HIV patients having reduced levels of CD4+ T cells.
    Type: Application
    Filed: May 13, 2020
    Publication date: May 20, 2021
    Applicants: UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College
    Inventors: Jay K. Kolls, Michael Zheng, Karen Norris, Heather Kling
  • KEXIN-DERIVED VACCINES TO PREVENT OR TREAT FUNGAL INFECTIONS
    Publication number: 20180318406
    Abstract: A vaccine is disclosed that promotes CD4+ T cell-independent host defense mechanisms to defend against infection by fungi such as Pneumocystis spp. The vaccine may be used to prevent or to treat fungal infections. The novel vaccine can provide protective immunity, even for immunocompromised individuals such as HIV patients having reduced levels of CD4+ T cells.
    Type: Application
    Filed: July 13, 2018
    Publication date: November 8, 2018
    Applicants: UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College
    Inventors: Jay K. Kolls, Michael Zheng, Karen Norris, Heather Kling
  • KEXIN-DERIVED VACCINES TO PREVENT OR TREAT FUNGAL INFECTIONS
    Publication number: 20170173127
    Abstract: A vaccine is disclosed that promotes CD4+ T cell-independent host defense mechanisms to defend against infection by fungi such as Pneumocystis spp. The vaccine may be used to prevent or to treat fimgal infections. The novel vaccine can provide protective immunity, even for immunocompromised individuals such as HIV patients having reduced levels of CD4+ T cells.
    Type: Application
    Filed: February 27, 2017
    Publication date: June 22, 2017
    Applicants: University of Pittsburgh - of the Commonwealth System of Higher Education, Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College
    Inventors: JAY K. KOLLS, Michael Zheng, Karen Norris, Heather Kling
  • Kexin-derived vaccines to prevent or treat fungal infections
    Patent number: 9580704
    Abstract: A vaccine is disclosed that promotes CD4+ T cell-independent host defense mechanisms to defend against infection by fungi such as Pneumocystis spp. The vaccine may be used to prevent or to treat fungal infections. The novel vaccine can provide protective immunity, even for immunocompromised individuals such as HIV patients having reduced levels of CD4+ T cells.
    Type: Grant
    Filed: August 5, 2013
    Date of Patent: February 28, 2017
    Assignees: University of Pittsburgh—of the Commonwealth System of Higher Education, Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
    Inventors: Jay K. Kolls, Michael Zheng, Karen Norris, Heather Kling
  • Kexin-Derived Vaccines to Prevent or Treat Fungal Infections
    Publication number: 20130315857
    Abstract: A vaccine is disclosed that promotes CD4+ T cell-independent host defense mechanisms to defend against infection by fungi such as Pneumocystis spp. The vaccine may be used to prevent or to treat fungal infections. The novel vaccine can provide protective immunity, even for immunocompromised individuals such as HIV patients having reduced levels of CD4+ T cells.
    Type: Application
    Filed: August 5, 2013
    Publication date: November 28, 2013
    Applicants: BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE, UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
    Inventors: JAY K. KOLLS, ZHENG MINQUAN, KAREN NORRIS, HEATHER KLING